Form 8-K - Current report:
SEC Accession No. 0001193125-24-003924
Filing Date
2024-01-08
Accepted
2024-01-08 08:01:06
Documents
43
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d161867d8k.htm   iXBRL 8-K 23717
2 EX-99.1 d161867dex991.htm EX-99.1 41534
6 GRAPHIC g161867ex99_1p10g1.jpg GRAPHIC 366614
7 GRAPHIC g161867ex99_1p11g1.jpg GRAPHIC 314553
8 GRAPHIC g161867ex99_1p12g1.jpg GRAPHIC 331476
9 GRAPHIC g161867ex99_1p13g1.jpg GRAPHIC 365886
10 GRAPHIC g161867ex99_1p14g1.jpg GRAPHIC 241510
11 GRAPHIC g161867ex99_1p15g1.jpg GRAPHIC 390714
12 GRAPHIC g161867ex99_1p16g1.jpg GRAPHIC 301312
13 GRAPHIC g161867ex99_1p17g1.jpg GRAPHIC 416290
14 GRAPHIC g161867ex99_1p18g1.jpg GRAPHIC 393478
15 GRAPHIC g161867ex99_1p19g1.jpg GRAPHIC 372265
16 GRAPHIC g161867ex99_1p1g1.jpg GRAPHIC 192644
17 GRAPHIC g161867ex99_1p20g1.jpg GRAPHIC 344888
18 GRAPHIC g161867ex99_1p21g1.jpg GRAPHIC 368836
19 GRAPHIC g161867ex99_1p22g1.jpg GRAPHIC 448971
20 GRAPHIC g161867ex99_1p23g1.jpg GRAPHIC 460106
21 GRAPHIC g161867ex99_1p24g1.jpg GRAPHIC 404162
22 GRAPHIC g161867ex99_1p25g1.jpg GRAPHIC 366196
23 GRAPHIC g161867ex99_1p26g1.jpg GRAPHIC 443413
24 GRAPHIC g161867ex99_1p27g1.jpg GRAPHIC 416728
25 GRAPHIC g161867ex99_1p28g1.jpg GRAPHIC 421894
26 GRAPHIC g161867ex99_1p29g1.jpg GRAPHIC 161137
27 GRAPHIC g161867ex99_1p2g1.jpg GRAPHIC 906650
28 GRAPHIC g161867ex99_1p30g1.jpg GRAPHIC 333876
29 GRAPHIC g161867ex99_1p3g1.jpg GRAPHIC 180548
30 GRAPHIC g161867ex99_1p4g1.jpg GRAPHIC 244531
31 GRAPHIC g161867ex99_1p5g1.jpg GRAPHIC 292805
32 GRAPHIC g161867ex99_1p6g1.jpg GRAPHIC 342531
33 GRAPHIC g161867ex99_1p7g1.jpg GRAPHIC 390501
34 GRAPHIC g161867ex99_1p8g1.jpg GRAPHIC 234965
35 GRAPHIC g161867ex99_1p9g1.jpg GRAPHIC 246752
  Complete submission text file 0001193125-24-003924.txt   14938724

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA prme-20240108.xsd EX-101.SCH 2867
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE prme-20240108_lab.xml EX-101.LAB 17977
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prme-20240108_pre.xml EX-101.PRE 11269
37 EXTRACTED XBRL INSTANCE DOCUMENT d161867d8k_htm.xml XML 3339
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41536 | Film No.: 24518401
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)